The Visual Function Classification System: Translation, Validity, and Reliability of the Persian Version for Individuals with Cerebral Palsy.
Iranian journal of child neurology. · 01.01.2025 · 19 (3) · 45-51
DOI: 10.22037/ijcn.v19i3.47283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian journal of child neurology., erschienen am 01.01.2025. Verfasst von Marzieh Pashmdarfard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational Therapy, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
This study aimed to translate and develop the Persian version of The Visual Function Classification System (P-VFCS) while assessing its validity and reliability. Materials & Methods: The VFCS was created to classify visual function among individuals with Cerebral Palsy (CP). Until this point, no such classification system was available in Iran. Therefore, the VFCS underwent translation into Persian, with the original developer approving the back-translation. A panel of ten occupational therapists and ten parents evaluated the face validity. The Persian version of VFCS (P-VFCS) was administered to 156 participants with CP, aged 1 to 19 years (age range: 2 to 18 years; mean age: 9.1 years; standard deviation: 6.32 years). Inter-rater reliability was measured among 156 parents and four occupational therapists. Test-retest reliability was evaluated throughout two to four weeks with 77 parents and two occupational therapists.
Results
The inter-rater reliability of the weighted kappa between OTs and parents for the P-VFCS was 0.88 (95% confidence interval [CI], 0.62 to 0.89). The weighted kappa test-retest reliability for the P-VFCS was 0.91 (95% CI: 0.93 to 1.00) for occupational therapists and 0.90 (95% CI: 0.89 to 1.00) for parents. The face validity assessment revealed that 80% of parents of individuals with CP (8 out of 10) and 100% of occupational therapists (10 out of 10) found the P-VFCS suitable in translation and face validity quality.
Conclusion
The findings indicated that the P-VFCS is a reliable and valid classification system for classifying visual functions in individuals with CP within clinical settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Occupational Therapy, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Rehabilitation Research Center, Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
- Department of Paediatric Neuromuscular Disorders, University College London, London, UK.
- Proteomics Research Center, Department of Biostatistics, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Pashmdarfard, M., Amini, M., Hejazi-Shirmard, M., Zamiran, S., Baranello, G., Akbarzadeh Baghban, A., & Kalantari, M. (2025). The Visual Function Classification System: Translation, Validity, and Reliability of the Persian Version for Individuals with Cerebral Palsy. Iranian journal of child neurology., 19(3), 45-51. https://doi.org/10.22037/ijcn.v19i3.47283
Vancouver
Pashmdarfard M, Amini M, Hejazi-Shirmard M, Zamiran S, Baranello G, Akbarzadeh Baghban A, et al. The Visual Function Classification System: Translation, Validity, and Reliability of the Persian Version for Individuals with Cerebral Palsy. Iranian journal of child neurology.. 2025;19(3):45-51. doi:10.22037/ijcn.v19i3.47283
BibTeX
@article{Pashmdarfard2025,
author = {Pashmdarfard, Marzieh and Amini, Malek and Hejazi-Shirmard, Mahnaz and Zamiran, Sara and Baranello, Giovanni and Akbarzadeh Baghban, Alireza and Kalantari, Minoo},
title = {The Visual Function Classification System: Translation, Validity, and Reliability of the Persian Version for Individuals with Cerebral Palsy},
journal = {Iranian journal of child neurology.},
year = {2025},
volume = {19},
number = {3},
pages = {45--51},
doi = {10.22037/ijcn.v19i3.47283}
}
EUVIMED